Publication | Closed Access

Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's Lymphoma Ascites tumor in mice

Tumor BiologyAntitumor ActivitiesMedicineOncogenic AgentMalignant Blood DisorderPharmacologyPathologyCancer BiologyAnti-cancer AgentLymphoma Ascites TumorOncologyHmg-coa Reductase InhibitorCancer Research